Evidence map›Paper›PMID 32385077›Full record

ArticleApplied and environmental microbiology2020

Deglycosylation of the Isoflavone

Kenichi Nakamura, Shu Zhu, Katsuko Komatsu, Masao Hattori, Makoto Iwashima

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Enzymatic 1,4-addition of 2-hydroxy-3-keto-glucal for β-selective aryl-Chemical communications (Cambridge, England) · 2026
    Article
  3. Review
  4. Characterization of the initial degradation mechanism involved inApplied and environmental microbiology · 2025
    Article
  5. Review
  6. Review
  7. Flavonoids Biotransformation by Human Gut BacteriumJournal of microbiology and biotechnology · 2024
    Article
  8. Genomics and physiology ofMicrobial genomics · 2024
    Article
  9. Glycoside-metabolizing oxidoreductase D3dgpA from human gut bacterium.Frontiers in bioengineering and biotechnology · 2024
    Article
  10. Journal of microbiology and biotechnology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Biochemical Characterization of Pyranose Oxidase fromInternational journal of molecular sciences · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kenichi NakamuraFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
Shu ZhuInstitute of Natural Medicine, University of Toyama, Toyama, Japan.
Katsuko KomatsuInstitute of Natural Medicine, University of Toyama, Toyama, Japan.
Masao HattoriInstitute of Natural Medicine, University of Toyama, Toyama, Japan.
Makoto IwashimaFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan iwashima@suzuka-u.ac.jp.
University of Toyama · JPSuzuka University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A human intestinal bacterium strain related to

Indexed as

Bacterial ProteinsEubacterialesGlucoseGlucosidesGlycosylationIsoflavonesOxidation-ReductionRecombinant ProteinsBacterial ProteinsGlucoseGlucosidesIsoflavonespuerarinRecombinant ProteinsC-glucosidedeglycosylationGfo/Idh/MocAintestinal bacteriumoxidoreductasepuerarin

Identifiers

PMID32385077
PMCPMC7357486
OpenAlexW3023950663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.